Eli Lilly and Co (FRA:LLY1) SpecialCharges

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LLY1 Eli Lilly and Co FRA:LLY1
96 GF Score
Price €7.50
GF Value €8.91
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Eli Lilly and Co SpecialCharges?

Special Charges only applies to banks.

FRA:LLY1
96GF Score
Eli Lilly and Co FRA:LLY1
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eli Lilly and Co (FRA:LLY1) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of €7.50 is trading 15.8% below its estimated GF Value™ of €8.91. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for FRA:LLY1:

  • SpecialCharges:
  • GF Value™: €8.91 vs. price of €7.50 (15.8% below fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the FRA:LLY1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
96GF Score

Get the complete analysis for FRA:LLY1

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.50
Price
€8.91
GF Value